{"recordsFiltered":48523,"recordsTotal":48523,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=26700","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=26100","results":[{"registry_id":"NCT04417530","publication_url":"https://clinicaltrials.gov/study/NCT04417530","title":"A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma","has_exemption":true,"start_date":"2020-08-05","completion_date":"2024-04-22","has_results":false,"results_due":false,"sponsor_name":"Aura Biosciences","sponsor_slug":"aura-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093362","publication_url":"https://clinicaltrials.gov/study/NCT04093362","title":"A Phase 3, Open-Label, Randomized Study of Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements FOENIX-CCA3","has_exemption":false,"start_date":"2021-01-06","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04669145","publication_url":"https://clinicaltrials.gov/study/NCT04669145","title":"Single-Shot Versus Continuous Regional Anesthesia for Treating Acute Postoperative Pain in Pediatric Orthopaedic Surgery: A Prospective Randomized Trial","has_exemption":false,"start_date":"2021-06-24","completion_date":"2024-04-22","has_results":false,"results_due":true,"sponsor_name":"Ochsner Health System","sponsor_slug":"ochsner-health-system","status":"overdue","is_pact":false,"days_late":365},{"registry_id":"NCT05296525","publication_url":"https://clinicaltrials.gov/study/NCT05296525","title":"A Phase I/II Multicenter Study Evaluating the Safety and Efficacy of Allogeneic GDA-201 Natural Killer Cells in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-07-05","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"Gamida Cell ltd","sponsor_slug":"gamida-cell-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05583591","publication_url":"https://clinicaltrials.gov/study/NCT05583591","title":"Prospective, Randomized Controlled Study Comparing Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma (COMPETE)","has_exemption":false,"start_date":"2022-10-01","completion_date":"2024-04-22","has_results":false,"results_due":true,"sponsor_name":"Diablo Eye Associates","sponsor_slug":"diablo-eye-associates","status":"overdue","is_pact":false,"days_late":365},{"registry_id":"NCT05772702","publication_url":"https://clinicaltrials.gov/study/NCT05772702","title":"Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression (CLACS): Single-Site Open-Label Pilot Study","has_exemption":false,"start_date":"2023-02-13","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"Electromedical Products International, Inc.","sponsor_slug":"electromedical-products-international-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05574062","publication_url":"https://clinicaltrials.gov/study/NCT05574062","title":"Evaluation of the MiniMed 780 System in Young Paediatric Subjects (2-6 Years Old) With Type 1 Diabetes in a Home Setting (LENNY)","has_exemption":false,"start_date":"2023-03-24","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"Medtronic MiniMed, Inc.","sponsor_slug":"medtronic-minimed-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05528588","publication_url":"https://clinicaltrials.gov/study/NCT05528588","title":"Efficacy of Furoscix in Heart Failure Patients With Diuretic Resistance","has_exemption":false,"start_date":"2023-06-02","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05978063","publication_url":"https://clinicaltrials.gov/study/NCT05978063","title":"A 2-part, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate-to-Severe Pruritus in Adult Subjects With Notalgia Paresthetica","has_exemption":false,"start_date":"2023-08-01","completion_date":"2024-04-22","has_results":false,"results_due":true,"sponsor_name":"Cara Therapeutics, Inc.","sponsor_slug":"cara-therapeutics-inc","status":"overdue","is_pact":false,"days_late":365},{"registry_id":"NCT05709821","publication_url":"https://clinicaltrials.gov/study/NCT05709821","title":"IMPORT-201: A Phase 1 First-in-Human Dose Finding/Randomized Phase 2 Study of IMM60 and Pembrolizumab for Advanced Melanoma and Metastatic NSCLC","has_exemption":false,"start_date":"2023-11-15","completion_date":"2024-04-22","has_results":false,"results_due":true,"sponsor_name":"iOx Therapeutics","sponsor_slug":"iox-therapeutics","status":"reported-late","is_pact":false,"days_late":316},{"registry_id":"NCT06219577","publication_url":"https://clinicaltrials.gov/study/NCT06219577","title":"Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance","has_exemption":false,"start_date":"2024-01-18","completion_date":"2024-04-22","has_results":true,"results_due":true,"sponsor_name":"Scripps Poway Eyecare and Optometry","sponsor_slug":"scripps-poway-eyecare-and-optometry","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03548961","publication_url":"https://clinicaltrials.gov/study/NCT03548961","title":"GI-116: Phase II Study of Organ Preservation in Early Rectal Cancer Patients","has_exemption":false,"start_date":"2018-05-11","completion_date":"2024-04-23","has_results":false,"results_due":true,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"overdue","is_pact":false,"days_late":364},{"registry_id":"NCT03675282","publication_url":"https://clinicaltrials.gov/study/NCT03675282","title":"Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and Controls","has_exemption":false,"start_date":"2018-08-14","completion_date":"2024-04-23","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03947216","publication_url":"https://clinicaltrials.gov/study/NCT03947216","title":"Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease","has_exemption":false,"start_date":"2020-10-23","completion_date":"2024-04-23","has_results":false,"results_due":true,"sponsor_name":"University Hospital, Strasbourg, France","sponsor_slug":"university-hospital-strasbourg-france","status":"overdue","is_pact":false,"days_late":364},{"registry_id":"NCT04643457","publication_url":"https://clinicaltrials.gov/study/NCT04643457","title":"A Phase I/IIA, Randomized, Placebo-Controlled, Single-Ascending Dose (Part A, Participant- and Investigator-Blind) and Repeated-Dose (Part B, Participant-, Investigator-, and Sponsor-Blind) Study to Investigate the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants (Part A) and in Study Participants With Moderate-to-Severe Atopic Dermatitis (Part B)","has_exemption":true,"start_date":"2020-11-27","completion_date":"2024-04-23","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05282121","publication_url":"https://clinicaltrials.gov/study/NCT05282121","title":"Randomised, Open-label and Parallel Group Trial to Investigate the Effects of Oral BI 685509 Alone or in Combination With Empagliflozin on Portal Hypertension After 8 Weeks Treatment in Patients With Clinically Significant Portal Hypertension (CSPH) in Compensated Cirrhosis","has_exemption":false,"start_date":"2022-06-28","completion_date":"2024-04-23","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05681715","publication_url":"https://clinicaltrials.gov/study/NCT05681715","title":"An Open-label, Crossover Study to Evaluate Rozanolixizumab Self-administration by Study Participants With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2023-04-17","completion_date":"2024-04-23","has_results":true,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05323630","publication_url":"https://clinicaltrials.gov/study/NCT05323630","title":"Evaluation of the Use of the Renuvion APR System in the Labia","has_exemption":false,"start_date":"2023-04-19","completion_date":"2024-04-23","has_results":true,"results_due":true,"sponsor_name":"Apyx Medical","sponsor_slug":"apyx-medical","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05990387","publication_url":"https://clinicaltrials.gov/study/NCT05990387","title":"Mirabegron and Physiological Function in Cold Environments - Aim 1","has_exemption":false,"start_date":"2023-07-19","completion_date":"2024-04-23","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06604013","publication_url":"https://clinicaltrials.gov/study/NCT06604013","title":"Class III Obesity and Periodontitis: Gingival Crevicular Fluid of Adiponectin and Resistin As Predictable Implement in Staging and Grading System and Effects of Periodontal Therapy","has_exemption":false,"start_date":"2023-09-10","completion_date":"2024-04-23","has_results":false,"results_due":true,"sponsor_name":"Al-Azhar University","sponsor_slug":"al-azhar-university","status":"overdue","is_pact":false,"days_late":364},{"registry_id":"NCT04626947","publication_url":"https://clinicaltrials.gov/study/NCT04626947","title":"Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).","has_exemption":false,"start_date":"2021-10-14","completion_date":"2024-04-24","has_results":true,"results_due":true,"sponsor_name":"David Binion, MD","sponsor_slug":"david-binion-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04681677","publication_url":"https://clinicaltrials.gov/study/NCT04681677","title":"Phase II Study of Patients With Recurrent Glioblastoma Multiforme Treated With Maximal Safe Neurosurgical Resection and Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent Electronic Brachytherapy System and Bevacizumab","has_exemption":false,"start_date":"2021-11-02","completion_date":"2024-04-24","has_results":false,"results_due":true,"sponsor_name":"Xoft, Inc.","sponsor_slug":"xoft-inc","status":"overdue","is_pact":false,"days_late":363},{"registry_id":"NCT05392751","publication_url":"https://clinicaltrials.gov/study/NCT05392751","title":"Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa","has_exemption":false,"start_date":"2022-06-02","completion_date":"2024-04-24","has_results":false,"results_due":true,"sponsor_name":"Endogena Therapeutics, Inc","sponsor_slug":"endogena-therapeutics-inc","status":"overdue","is_pact":false,"days_late":363},{"registry_id":"NCT05463731","publication_url":"https://clinicaltrials.gov/study/NCT05463731","title":"Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease","has_exemption":true,"start_date":"2022-08-01","completion_date":"2024-04-24","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05280756","publication_url":"https://clinicaltrials.gov/study/NCT05280756","title":"Home-based Transcranial Direct-current Stimulation (tDCS) for Prevention of Suicidal Ideation","has_exemption":false,"start_date":"2023-09-21","completion_date":"2024-04-24","has_results":true,"results_due":true,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06003049","publication_url":"https://clinicaltrials.gov/study/NCT06003049","title":"An Investigator-Initiated, Single Center, Prospective, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety and Efficacy of OnabotulinumtoxinA (BOTOX®) in Adults With Moderate Chronic Obstructive Pulmonary Disease (COPD)","has_exemption":false,"start_date":"2023-10-01","completion_date":"2024-04-24","has_results":false,"results_due":true,"sponsor_name":"RMW Testing","sponsor_slug":"rmw-testing","status":"overdue","is_pact":false,"days_late":363},{"registry_id":"NCT06027229","publication_url":"https://clinicaltrials.gov/study/NCT06027229","title":"Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations","has_exemption":true,"start_date":"2023-11-20","completion_date":"2024-04-24","has_results":true,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02317887","publication_url":"https://clinicaltrials.gov/study/NCT02317887","title":"A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis","has_exemption":true,"start_date":"2015-02-11","completion_date":"2024-04-25","has_results":true,"results_due":false,"sponsor_name":"VegaVect, Inc.","sponsor_slug":"vegavect-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03863184","publication_url":"https://clinicaltrials.gov/study/NCT03863184","title":"A Multiple-center Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab (ALR) With an Expansion Cohort of Acalabrutinib-Lenalidomide-Obinutuzumab (ALO) in Patients With Previous Untreated Mantle Cell Lymphoma","has_exemption":false,"start_date":"2019-10-11","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04821830","publication_url":"https://clinicaltrials.gov/study/NCT04821830","title":"Vigor and the LDR in Parkinson Disease","has_exemption":false,"start_date":"2020-02-12","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04249232","publication_url":"https://clinicaltrials.gov/study/NCT04249232","title":"Abaloparatide Versus Placebo for Pelvic Fracture Healing - A Phase 2 Randomized Controlled Trial","has_exemption":false,"start_date":"2020-09-17","completion_date":"2024-04-25","has_results":false,"results_due":true,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"overdue","is_pact":false,"days_late":362},{"registry_id":"NCT04549025","publication_url":"https://clinicaltrials.gov/study/NCT04549025","title":"Phase 2 Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab, an ICOS Agonist, in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen","has_exemption":false,"start_date":"2020-10-19","completion_date":"2024-04-25","has_results":false,"results_due":true,"sponsor_name":"Jounce Therapeutics, Inc.","sponsor_slug":"jounce-therapeutics-inc","status":"overdue","is_pact":false,"days_late":362},{"registry_id":"NCT04482582","publication_url":"https://clinicaltrials.gov/study/NCT04482582","title":"Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients","has_exemption":false,"start_date":"2021-06-01","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":false,"days_late":295},{"registry_id":"NCT04892446","publication_url":"https://clinicaltrials.gov/study/NCT04892446","title":"A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-11-09","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05625373","publication_url":"https://clinicaltrials.gov/study/NCT05625373","title":"The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection","has_exemption":false,"start_date":"2022-10-25","completion_date":"2024-04-25","has_results":false,"results_due":true,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05629962","publication_url":"https://clinicaltrials.gov/study/NCT05629962","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19","has_exemption":false,"start_date":"2022-11-25","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"Atea Pharmaceuticals, Inc.","sponsor_slug":"atea-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":17},{"registry_id":"NCT05419999","publication_url":"https://clinicaltrials.gov/study/NCT05419999","title":"Safety, Feasibility, and Benefits of Transcranial Direct Current Stimulation (tDCS) in Human Subjects With Posttraumatic Stress Disorder (PTSD) Receiving an Exposure-based, Behavioral Therapy","has_exemption":false,"start_date":"2023-01-09","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"reported-late","is_pact":false,"days_late":18},{"registry_id":"NCT05795153","publication_url":"https://clinicaltrials.gov/study/NCT05795153","title":"A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.","has_exemption":false,"start_date":"2023-04-05","completion_date":"2024-04-25","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05874713","publication_url":"https://clinicaltrials.gov/study/NCT05874713","title":"A Phase 2, Multi-Center, Randomized, Observer-Blind Study, to Evaluate Safety and Immunogenicity of Homologous or Heterologous Priming and Booster Vaccinations With H5N8 or H5N6 MF59-adjuvanted, Cell Culture-derived Influenza Vaccine in Healthy Subjects ≥18 Years of Age","has_exemption":true,"start_date":"2023-06-07","completion_date":"2024-04-25","has_results":false,"results_due":false,"sponsor_name":"Seqirus","sponsor_slug":"seqirus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06552481","publication_url":"https://clinicaltrials.gov/study/NCT06552481","title":"A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects","has_exemption":false,"start_date":"2023-08-16","completion_date":"2024-04-25","has_results":false,"results_due":true,"sponsor_name":"The Metis Foundation","sponsor_slug":"the-metis-foundation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03400332","publication_url":"https://clinicaltrials.gov/study/NCT03400332","title":"A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers","has_exemption":false,"start_date":"2018-02-12","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04539574","publication_url":"https://clinicaltrials.gov/study/NCT04539574","title":"Validation of a Multi-Parametric Ultra-High Field MRI Protocol for Central Nervous System Malignancy","has_exemption":false,"start_date":"2020-09-04","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04390763","publication_url":"https://clinicaltrials.gov/study/NCT04390763","title":"A Phase II, Open Label, Randomized, Parallel Arm Study of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy Gemcitabine/Nab-paclitaxel, and Gemcitabine/Nab-paclitaxel Alone in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)","has_exemption":false,"start_date":"2020-10-16","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05447052","publication_url":"https://clinicaltrials.gov/study/NCT05447052","title":"The Biomimetic Stent and Vascular Functions Study-The MIMICS FLOW STUDY","has_exemption":false,"start_date":"2021-04-26","completion_date":"2024-04-26","has_results":false,"results_due":true,"sponsor_name":"University Hospital, Essen","sponsor_slug":"university-hospital-essen","status":"overdue","is_pact":false,"days_late":361},{"registry_id":"NCT04876391","publication_url":"https://clinicaltrials.gov/study/NCT04876391","title":"An Open-label, Long-term Extension Trial of Spesolimab Treatment in Adult Patients With Hidradenitis Suppurativa (HS)","has_exemption":false,"start_date":"2021-08-24","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05312385","publication_url":"https://clinicaltrials.gov/study/NCT05312385","title":"A Phase 3, Multicenter, Randomized, Controlled, Open Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)","has_exemption":false,"start_date":"2022-04-28","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Sedana Medical","sponsor_slug":"sedana-medical","status":"reported-late","is_pact":false,"days_late":25},{"registry_id":"NCT05669924","publication_url":"https://clinicaltrials.gov/study/NCT05669924","title":"The Neural Correlates of and Effects of Methylphenidate on Acute Pain Dynamics","has_exemption":false,"start_date":"2022-09-19","completion_date":"2024-04-26","has_results":false,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported-late","is_pact":false,"days_late":299},{"registry_id":"NCT05585879","publication_url":"https://clinicaltrials.gov/study/NCT05585879","title":"Outpatient Colonoscopy: Demonstrating Effective Salvage of Inadequate Colonoscopies Utilizing the Pure-Vu EVS System","has_exemption":false,"start_date":"2022-11-03","completion_date":"2024-04-26","has_results":false,"results_due":true,"sponsor_name":"Motus GI Medical Technologies Ltd","sponsor_slug":"motus-gi-medical-technologies-ltd","status":"overdue","is_pact":false,"days_late":361},{"registry_id":"NCT05709444","publication_url":"https://clinicaltrials.gov/study/NCT05709444","title":"A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease to Assess the Efficacy in Reducing Urinary Protein and Maintaining Podocyte Density and Function","has_exemption":false,"start_date":"2022-12-26","completion_date":"2024-04-26","has_results":false,"results_due":true,"sponsor_name":"Palatin Technologies, Inc","sponsor_slug":"palatin-technologies-inc","status":"overdue","is_pact":false,"days_late":361},{"registry_id":"NCT05764265","publication_url":"https://clinicaltrials.gov/study/NCT05764265","title":"An Open-label Extension Study to Investigate Efficacy, Safety and Tolerability of LTP001 in Participants With Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2023-03-27","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05984784","publication_url":"https://clinicaltrials.gov/study/NCT05984784","title":"A Phase1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2023-08-09","completion_date":"2024-04-26","has_results":true,"results_due":true,"sponsor_name":"Inmagene LLC","sponsor_slug":"inmagene-llc","status":"reported-late","is_pact":false,"days_late":111},{"registry_id":"NCT05947812","publication_url":"https://clinicaltrials.gov/study/NCT05947812","title":"A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression (the \"ACLR8-LR\" Study)","has_exemption":false,"start_date":"2023-08-01","completion_date":"2024-04-27","has_results":false,"results_due":true,"sponsor_name":"60P Australia Pty Ltd","sponsor_slug":"60p-australia-pty-ltd","status":"overdue","is_pact":false,"days_late":360},{"registry_id":"NCT03222570","publication_url":"https://clinicaltrials.gov/study/NCT03222570","title":"An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression","has_exemption":false,"start_date":"2018-02-26","completion_date":"2024-04-28","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":false,"days_late":1},{"registry_id":"NCT02553642","publication_url":"https://clinicaltrials.gov/study/NCT02553642","title":"A Prospectively Designed Study to Assess the Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)","has_exemption":false,"start_date":"2015-09-14","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02772562","publication_url":"https://clinicaltrials.gov/study/NCT02772562","title":"A Phase II Trial of Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy","has_exemption":false,"start_date":"2016-07-18","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01996436","publication_url":"https://clinicaltrials.gov/study/NCT01996436","title":"The Intra-arterial Vasospasm Trial - A Multi-center Randomized Study","has_exemption":false,"start_date":"2016-08-29","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Peng Roc Chen, MD","sponsor_slug":"peng-roc-chen-md","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03433274","publication_url":"https://clinicaltrials.gov/study/NCT03433274","title":"Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation","has_exemption":false,"start_date":"2018-06-15","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"reported-late","is_pact":false,"days_late":190},{"registry_id":"NCT03732677","publication_url":"https://clinicaltrials.gov/study/NCT03732677","title":"A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients With Muscle-Invasive Bladder Cancer.","has_exemption":false,"start_date":"2018-11-16","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03765983","publication_url":"https://clinicaltrials.gov/study/NCT03765983","title":"Phase II Trial of GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases","has_exemption":false,"start_date":"2019-02-11","completion_date":"2024-04-29","has_results":false,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":false,"days_late":282},{"registry_id":"NCT03888612","publication_url":"https://clinicaltrials.gov/study/NCT03888612","title":"A Phase 1/2, Open-label, Dose Escalation, and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":true,"start_date":"2019-03-01","completion_date":"2024-04-29","has_results":false,"results_due":false,"sponsor_name":"Arvinas Inc","sponsor_slug":"arvinas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03739996","publication_url":"https://clinicaltrials.gov/study/NCT03739996","title":"A Study of Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) to Maintain Viral Suppression in Adults Living With HIV-1","has_exemption":false,"start_date":"2019-12-31","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04434482","publication_url":"https://clinicaltrials.gov/study/NCT04434482","title":"A Phase Ib/II, Open-Label, Multi-Center, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-08-07","completion_date":"2024-04-29","has_results":false,"results_due":true,"sponsor_name":"Impact Therapeutics, Inc.","sponsor_slug":"impact-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":119},{"registry_id":"NCT04276558","publication_url":"https://clinicaltrials.gov/study/NCT04276558","title":"Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients","has_exemption":false,"start_date":"2020-10-13","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"RECORDATI GROUP","sponsor_slug":"recordati-group","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04278924","publication_url":"https://clinicaltrials.gov/study/NCT04278924","title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Persistent/Chronic Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2020-11-09","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04885530","publication_url":"https://clinicaltrials.gov/study/NCT04885530","title":"ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications","has_exemption":false,"start_date":"2021-06-08","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Susanna Naggie, MD","sponsor_slug":"susanna-naggie-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05089084","publication_url":"https://clinicaltrials.gov/study/NCT05089084","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome","has_exemption":true,"start_date":"2021-12-14","completion_date":"2024-04-29","has_results":true,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05732454","publication_url":"https://clinicaltrials.gov/study/NCT05732454","title":"A PHASE 2/3, TWO-PART STUDY TO EVALUATE THE EFFICACY AND LONG-TERM SAFETY WITH ORAL ETRASIMOD, 2 MG, ONCE DAILY IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH A HISTORY OF PRIOR SYSTEMIC TREATMENT FAILURE","has_exemption":false,"start_date":"2023-01-18","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05553639","publication_url":"https://clinicaltrials.gov/study/NCT05553639","title":"A Phase 1/2 Study of Replicating Arenavirus-based Vector(s) Encoding Prostate Cancer-Associated Antigens in Participants With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-05-23","completion_date":"2024-04-29","has_results":false,"results_due":true,"sponsor_name":"Hookipa Biotech GmbH","sponsor_slug":"hookipa-biotech-gmbh","status":"reported-late","is_pact":false,"days_late":175},{"registry_id":"NCT05820685","publication_url":"https://clinicaltrials.gov/study/NCT05820685","title":"Dronabinol On the Pain Experience (DOPE): a Pragmatic Randomized Clinical Trial","has_exemption":true,"start_date":"2023-07-27","completion_date":"2024-04-29","has_results":true,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06041646","publication_url":"https://clinicaltrials.gov/study/NCT06041646","title":"Characterization of Tachyphylaxis, Tolerance, and Withdrawal After Discontinuation of Igalmi in Frequently Agitated Schizophrenic or Bipolar Patients After 7 Days of PRN Treatment","has_exemption":false,"start_date":"2023-10-02","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"BioXcel Therapeutics Inc","sponsor_slug":"bioxcel-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":195},{"registry_id":"NCT05996198","publication_url":"https://clinicaltrials.gov/study/NCT05996198","title":"A Pilot Proof of Concept, Single Site Study to Assess the Effect of Exoskeletal Support on Motor Control Strategies in Individuals With Stroke","has_exemption":false,"start_date":"2024-01-03","completion_date":"2024-04-29","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01506141","publication_url":"https://clinicaltrials.gov/study/NCT01506141","title":"An Open-Label Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase® in Pediatric Patients With Hunter Syndrome and Cognitive Impairment","has_exemption":false,"start_date":"2010-08-01","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01476787","publication_url":"https://clinicaltrials.gov/study/NCT01476787","title":"A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy in Subjects With Previously Untreated Follicular Lymphoma","has_exemption":false,"start_date":"2011-12-29","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01837862","publication_url":"https://clinicaltrials.gov/study/NCT01837862","title":"A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas","has_exemption":false,"start_date":"2013-10-22","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Julie Krystal","sponsor_slug":"julie-krystal","status":"overdue","is_pact":true,"days_late":357},{"registry_id":"NCT02028559","publication_url":"https://clinicaltrials.gov/study/NCT02028559","title":"Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones","has_exemption":false,"start_date":"2014-01-31","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"overdue-cancelled","is_pact":true,"days_late":357},{"registry_id":"NCT01771679","publication_url":"https://clinicaltrials.gov/study/NCT01771679","title":"A Phase I/II, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects for Cutaneous Photoaging","has_exemption":false,"start_date":"2015-07-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Stemedica Cell Technologies, Inc.","sponsor_slug":"stemedica-cell-technologies-inc","status":"overdue","is_pact":true,"days_late":357},{"registry_id":"NCT02464969","publication_url":"https://clinicaltrials.gov/study/NCT02464969","title":"A Randomized, Open-Label, Active Controlled, Safety and Descriptive Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic Event","has_exemption":false,"start_date":"2015-11-22","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03121586","publication_url":"https://clinicaltrials.gov/study/NCT03121586","title":"A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia","has_exemption":false,"start_date":"2017-01-31","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"ACADIA Pharmaceuticals Inc.","sponsor_slug":"acadia-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":14},{"registry_id":"NCT03106740","publication_url":"https://clinicaltrials.gov/study/NCT03106740","title":"Imaging Glia-mediated NeuroInflammation and Treatment Efficacy (the IGNITE Study)","has_exemption":false,"start_date":"2017-10-10","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Marco Loggia","sponsor_slug":"marco-loggia","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03235544","publication_url":"https://clinicaltrials.gov/study/NCT03235544","title":"A Phase 2, Open-Label, 2-Cohort, Multicenter Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)","has_exemption":false,"start_date":"2017-11-20","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03488667","publication_url":"https://clinicaltrials.gov/study/NCT03488667","title":"A Phase II Study of Perioperative mFOLFOX (Fluorouracil, Leucovorin, and Oxaliplatin) Chemotherapy Plus Pembrolizumab(MK-3475) Combination in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach (MISP #52216)","has_exemption":false,"start_date":"2018-06-27","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"reported-late","is_pact":false,"days_late":78},{"registry_id":"NCT03567720","publication_url":"https://clinicaltrials.gov/study/NCT03567720","title":"A Phase 2 Multi-Cohort, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus Electroporation in Combination With Pembrolizumab +/- Chemotherapy in Patients With Inoperable Locally Advanced/Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2018-10-11","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"OncoSec Medical Incorporated","sponsor_slug":"oncosec-medical-incorporated","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT03199885","publication_url":"https://clinicaltrials.gov/study/NCT03199885","title":"A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2019-04-05","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":13},{"registry_id":"NCT03936894","publication_url":"https://clinicaltrials.gov/study/NCT03936894","title":"A Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) Assessing Safety and Biomarker Changes in Boys With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2019-05-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04019197","publication_url":"https://clinicaltrials.gov/study/NCT04019197","title":"Effects of GLP-l Receptor Agonists on Cardiometabolic Alterations in HIV-associated Lipohypertrophy","has_exemption":false,"start_date":"2019-05-16","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Case Western Reserve University","sponsor_slug":"case-western-reserve-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03810417","publication_url":"https://clinicaltrials.gov/study/NCT03810417","title":"Single System Double Blinded Trial to Evaluate the Effect of Pre-operative Treatment With DigiFab to Prevent Post-operative Acute Kidney Injury (AKI) in Patients at High Risk for AKI Undergoing Cardiac Bypass Graft Surgery","has_exemption":false,"start_date":"2019-07-22","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"reported-late","is_pact":false,"days_late":7},{"registry_id":"NCT04138927","publication_url":"https://clinicaltrials.gov/study/NCT04138927","title":"A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia","has_exemption":false,"start_date":"2019-10-30","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03952468","publication_url":"https://clinicaltrials.gov/study/NCT03952468","title":"Combined Transcranial Magnetic Stimulation and Brief Cognitive Therapy to Reduce Suicide Behavior in High-Risk Veterans","has_exemption":false,"start_date":"2019-11-04","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03981055","publication_url":"https://clinicaltrials.gov/study/NCT03981055","title":"Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.","has_exemption":false,"start_date":"2020-01-23","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"reported-late","is_pact":false,"days_late":154},{"registry_id":"NCT04585035","publication_url":"https://clinicaltrials.gov/study/NCT04585035","title":"A Phase 1/2, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of D-1553 in Subjects With Advanced or Metastatic Solid Tumors With KRasG12C Mutation","has_exemption":false,"start_date":"2020-10-02","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"InventisBio Co., Ltd","sponsor_slug":"inventisbio-co-ltd","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04404686","publication_url":"https://clinicaltrials.gov/study/NCT04404686","title":"Vaginal Indomethacin Versus Oral Nifedipine for Preterm Labor; a Randomized Controlled Trial","has_exemption":false,"start_date":"2020-10-31","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Hadassah Medical Organization","sponsor_slug":"hadassah-medical-organization","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04545541","publication_url":"https://clinicaltrials.gov/study/NCT04545541","title":"Can Nebulised HepArin Reduce morTality and Time to Extubation in Patients With COVID-19 Requiring Mechanical Ventilation Meta-Trial (CHARTER-MT): Protocol for an Investigator-initiated International Meta-trial of Randomised Studies","has_exemption":false,"start_date":"2020-11-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Australian National University","sponsor_slug":"australian-national-university","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04720417","publication_url":"https://clinicaltrials.gov/study/NCT04720417","title":"A Phase II Trial of Defactinib (VS-6063) Combined With VS-6766 (CH5126766) in Patients With Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2021-01-26","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04228276","publication_url":"https://clinicaltrials.gov/study/NCT04228276","title":"Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2021-02-05","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04993014","publication_url":"https://clinicaltrials.gov/study/NCT04993014","title":"Circulating Tumor Cells and Adjuvant Treatment De-escalation After Neoadjuvant Therapy With Trastuzumab and Pertuzumab for HER2 Positive Early Breast Cancer","has_exemption":false,"start_date":"2021-03-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"AC Camargo Cancer Center","sponsor_slug":"ac-camargo-cancer-center","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04579757","publication_url":"https://clinicaltrials.gov/study/NCT04579757","title":"An Open-Label Phase Ib/II Study of Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2021-03-05","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Hutchmed","sponsor_slug":"hutchmed","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04505163","publication_url":"https://clinicaltrials.gov/study/NCT04505163","title":"Left Atrial Posterior Wall Isolation in Conjunction With Pulmonary Vein Isolation Using the Cryoballoon for Treatment of Persistent Atrial Fibrillation (PIVoTAL) - IDE Trial","has_exemption":false,"start_date":"2021-04-30","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Dignity Health Medical Foundation","sponsor_slug":"dignity-health-medical-foundation","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06141941","publication_url":"https://clinicaltrials.gov/study/NCT06141941","title":"Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes","has_exemption":false,"start_date":"2021-06-01","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04656041","publication_url":"https://clinicaltrials.gov/study/NCT04656041","title":"A Phase II Study of Neoadjuvant NAPOX Followed by Chemoradiation With Paclitaxel and Carboplatin in Locally Advanced Esophagogastric Cancer","has_exemption":false,"start_date":"2021-06-29","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04843709","publication_url":"https://clinicaltrials.gov/study/NCT04843709","title":"An Open-Label, Multi-center, Phase I/II Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Anti-Tumor Activity and Pharmacokinetics of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2021-07-26","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Shanghai Miracogen Inc.","sponsor_slug":"shanghai-miracogen-inc","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT04882878","publication_url":"https://clinicaltrials.gov/study/NCT04882878","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus","has_exemption":true,"start_date":"2021-08-20","completion_date":"2024-04-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04994444","publication_url":"https://clinicaltrials.gov/study/NCT04994444","title":"Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts","has_exemption":false,"start_date":"2021-09-01","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05070260","publication_url":"https://clinicaltrials.gov/study/NCT05070260","title":"A Randomized, Double Blind, Multicenter, Multinational, Placebo Controlled, Parallel Group, Single Dose, Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke","has_exemption":false,"start_date":"2021-09-23","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Acticor Biotech","sponsor_slug":"acticor-biotech","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT03862924","publication_url":"https://clinicaltrials.gov/study/NCT03862924","title":"Health Effects of the Standardized Research E-Cigarette for Harm Reduction in Smokers With HIV","has_exemption":false,"start_date":"2022-03-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"reported-late","is_pact":false,"days_late":148},{"registry_id":"NCT05016609","publication_url":"https://clinicaltrials.gov/study/NCT05016609","title":"Same-visit Hepatitis C Testing and Treatment to Accelerate Cure Among People Who Inject Drugs: a Cluster Randomised Control Trial (The QuickStart Study)","has_exemption":false,"start_date":"2022-03-09","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Macfarlane Burnet Institute for Medical Research and Public Health Ltd","sponsor_slug":"macfarlane-burnet-institute-for-medical-research-and-public-health-ltd","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05320588","publication_url":"https://clinicaltrials.gov/study/NCT05320588","title":"A Phase 1/2 Study of BIO-106 As Monotherapy or In Combination With Pembrolizumab in Patients With Advanced Cancers (StarBridge-1)","has_exemption":false,"start_date":"2022-03-25","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"BiOneCure Therapeutics Inc.","sponsor_slug":"bionecure-therapeutics-inc","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05270122","publication_url":"https://clinicaltrials.gov/study/NCT05270122","title":"ThrombX Retriever for Acute Ischemic Stroke Trial","has_exemption":false,"start_date":"2022-05-31","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"ThrombX Medical","sponsor_slug":"thrombx-medical","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05083442","publication_url":"https://clinicaltrials.gov/study/NCT05083442","title":"A Feasibility Study Addressing the Adjunct Use of Low-Level Laser to Mayo Lifestyle Modification Education and Wellness Coaching for Reducing Central Adiposity and Fat Mass","has_exemption":false,"start_date":"2022-06-01","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05822232","publication_url":"https://clinicaltrials.gov/study/NCT05822232","title":"A Randomized Controlled Trial Comparing the FreeStyle Libre 2 Continuous Glucose Monitoring vs Point of Care Glucose Testing for the Management of Subjects With Type 2 Diabetes After Hospital Discharge: FreeStyle Libre 2 Discharge Trial","has_exemption":false,"start_date":"2022-08-17","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Palo Alto Medical Foundation","sponsor_slug":"palo-alto-medical-foundation","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05298033","publication_url":"https://clinicaltrials.gov/study/NCT05298033","title":"Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo: A Phase 2A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial","has_exemption":false,"start_date":"2022-09-07","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported-late","is_pact":false,"days_late":286},{"registry_id":"NCT05716295","publication_url":"https://clinicaltrials.gov/study/NCT05716295","title":"A Phase 1/2, Open-Label, Multicenter Study of MDK-703 as a Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With Advanced or Metastatic Solid Tumors (ORCHID-1)","has_exemption":false,"start_date":"2023-02-08","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Medikine, Inc.","sponsor_slug":"medikine-inc","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT03749317","publication_url":"https://clinicaltrials.gov/study/NCT03749317","title":"A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis","has_exemption":false,"start_date":"2023-02-20","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"IVIEW Therapeutics Inc.","sponsor_slug":"iview-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":330},{"registry_id":"NCT05692245","publication_url":"https://clinicaltrials.gov/study/NCT05692245","title":"Dexamethasone vs Ondansetron as the First-line Antiemetic to Prevent Postoperative Nausea and Vomiting After Cesarean Delivery","has_exemption":false,"start_date":"2023-03-30","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported-late","is_pact":false,"days_late":269},{"registry_id":"NCT06154200","publication_url":"https://clinicaltrials.gov/study/NCT06154200","title":"A Pilot Randomized Controlled Trial of Eyelid Androgen Treatment in Dry Eye","has_exemption":false,"start_date":"2023-04-02","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Southern California College of Optometry at Marshall B. Ketchum University","sponsor_slug":"southern-california-college-of-optometry-at-marshall-b-ketchum-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05320939","publication_url":"https://clinicaltrials.gov/study/NCT05320939","title":"Immunological Basis for Mepolizumab Activity in COPD","has_exemption":false,"start_date":"2023-04-30","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Temple University","sponsor_slug":"temple-university","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05529134","publication_url":"https://clinicaltrials.gov/study/NCT05529134","title":"A Double-blind, Randomized, Intra-patient Placebo- Controlled, Multiple Dose Study of PTW-002 Evaluating Safety, Proof of Mechanism, Preliminary Efficacy, and Systemic Exposure in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa (DDEB / RDEB) Due to Mutation(s) in Exon 73 of the COL7A1 Gene","has_exemption":false,"start_date":"2023-04-30","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Phoenicis Therapeutics","sponsor_slug":"phoenicis-therapeutics","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05800847","publication_url":"https://clinicaltrials.gov/study/NCT05800847","title":"Gabapentin Following Arthroscopic Rotator Cuff Repair: Evaluation of Postoperative Opioid Use and Sleep Quality","has_exemption":false,"start_date":"2023-04-30","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Hughston Clinic","sponsor_slug":"hughston-clinic","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05869500","publication_url":"https://clinicaltrials.gov/study/NCT05869500","title":"Left Bundle Area Pacing Vs. Right Ventricular Pacing in Patients With Normal Left Ventricular Function -The Boston Pace Study","has_exemption":false,"start_date":"2023-05-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT05904769","publication_url":"https://clinicaltrials.gov/study/NCT05904769","title":"Non-invasive Measurement of Blood Glucose, Blood Pressure and Extrapolation of QRS Complex Using a Wrist Wearable Photoplethysmography Sensor","has_exemption":true,"start_date":"2023-05-31","completion_date":"2024-04-30","has_results":true,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06753526","publication_url":"https://clinicaltrials.gov/study/NCT06753526","title":"L-Arginine Role for Stone Lower Ureter : A Randomized Control Study","has_exemption":false,"start_date":"2023-07-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Sohag University","sponsor_slug":"sohag-university","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06996301","publication_url":"https://clinicaltrials.gov/study/NCT06996301","title":"Clinical Validity and Utility of PCR Compared to Conventional Culture and Sensitivity Testing for the Management of Complicated Urinary Tract Infections in Adults.","has_exemption":false,"start_date":"2023-07-31","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Doc Lab Inc","sponsor_slug":"doc-lab-inc","status":"reported-late","is_pact":false,"days_late":30},{"registry_id":"NCT06028386","publication_url":"https://clinicaltrials.gov/study/NCT06028386","title":"A Prospective Pilot Study Evaluating Wound Closure With the Application of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers","has_exemption":false,"start_date":"2023-08-15","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Arch Therapeutics","sponsor_slug":"arch-therapeutics","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06071754","publication_url":"https://clinicaltrials.gov/study/NCT06071754","title":"Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057","has_exemption":true,"start_date":"2023-09-01","completion_date":"2024-04-30","has_results":true,"results_due":false,"sponsor_name":"Masimo Corporation","sponsor_slug":"masimo-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06064617","publication_url":"https://clinicaltrials.gov/study/NCT06064617","title":"Accommodative Behaviors in Multifocal Contact Lenses","has_exemption":false,"start_date":"2023-11-01","completion_date":"2024-04-30","has_results":true,"results_due":true,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"reported-late","is_pact":false,"days_late":90},{"registry_id":"NCT06389916","publication_url":"https://clinicaltrials.gov/study/NCT06389916","title":"Euclid Phoenix Lens Design Trial Phase 1","has_exemption":false,"start_date":"2023-11-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Euclid Systems Corporation","sponsor_slug":"euclid-systems-corporation","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06088862","publication_url":"https://clinicaltrials.gov/study/NCT06088862","title":"A Randomized Study to Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With Nicotine Replacement Therapy (NRT)","has_exemption":false,"start_date":"2023-12-27","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Rose Research Center, LLC","sponsor_slug":"rose-research-center-llc","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06317766","publication_url":"https://clinicaltrials.gov/study/NCT06317766","title":"Histological Study of the Effects of a 2910 nm Fiber Laser Technology","has_exemption":false,"start_date":"2024-02-05","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"FA Corporation","sponsor_slug":"fa-corporation","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT06241742","publication_url":"https://clinicaltrials.gov/study/NCT06241742","title":"A Phase-2 Study to Evaluate the Ability of HT-6184 to Attenuate Diagnostic Biomarkers of Post-procedure Acute Inflammation and Manage Pain Following Third Molar Extraction","has_exemption":true,"start_date":"2024-02-12","completion_date":"2024-04-30","has_results":false,"results_due":false,"sponsor_name":"Halia Therapeutics, Inc.","sponsor_slug":"halia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637384","publication_url":"https://clinicaltrials.gov/study/NCT06637384","title":"Effects of Hyaluronic Acid and Corticosteroid in Post Extraction Wound Healing of Diabetic Patients","has_exemption":false,"start_date":"2024-03-01","completion_date":"2024-04-30","has_results":false,"results_due":true,"sponsor_name":"Rimsha Rasheed","sponsor_slug":"rimsha-rasheed","status":"overdue","is_pact":false,"days_late":357},{"registry_id":"NCT02484950","publication_url":"https://clinicaltrials.gov/study/NCT02484950","title":"A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Arthroscopic Rotator Cuff Repair","has_exemption":false,"start_date":"2015-11-15","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03049306","publication_url":"https://clinicaltrials.gov/study/NCT03049306","title":"Propranolol for Sleep Apnea Therapy","has_exemption":false,"start_date":"2017-02-15","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03301220","publication_url":"https://clinicaltrials.gov/study/NCT03301220","title":"A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma","has_exemption":true,"start_date":"2017-11-07","completion_date":"2024-05-01","has_results":true,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03427866","publication_url":"https://clinicaltrials.gov/study/NCT03427866","title":"A Phase II Study of Ruxolitinib Pre-, During- and Post-Hematopoietic Stem Cell Transplantation for Patients With Primary or Secondary Myelofibrosis.","has_exemption":false,"start_date":"2018-08-28","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":false,"days_late":208},{"registry_id":"NCT03804060","publication_url":"https://clinicaltrials.gov/study/NCT03804060","title":"A Multicenter, Prospective, Randomized-controlled Trial to Assess the Safety and Feasibility of Cooling as an Adjunctive Therapy to Thrombectomy and Reperfusion in Patients With Acute Cerebral Ischemia and Stroke","has_exemption":false,"start_date":"2019-05-23","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"ZOLL Circulation, Inc., USA","sponsor_slug":"zoll-circulation-inc-usa","status":"reported-late","is_pact":false,"days_late":342},{"registry_id":"NCT04181827","publication_url":"https://clinicaltrials.gov/study/NCT04181827","title":"A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA, Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects With Relapsed and Lenalidomide-Refractory Multiple Myeloma","has_exemption":false,"start_date":"2020-06-12","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04455724","publication_url":"https://clinicaltrials.gov/study/NCT04455724","title":"Negative Pressure Incisional Wound Therapy for High-risk Ventral Hernia Repair: a Randomized Controlled Trial","has_exemption":false,"start_date":"2020-12-14","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT04523350","publication_url":"https://clinicaltrials.gov/study/NCT04523350","title":"Randomized Multi-Center, Subject and Evaluator Blinded, Parallel-Group Study to Evaluate the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) Compared With Standard of Care Transcatheter Arterial Embolization (TAE) / Transcatheter Arterial Chemoembolization (cTACE) for Vascular Occlusion of Hypervascular Tumors; A Pivotal Study","has_exemption":false,"start_date":"2021-01-04","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Instylla, Inc.","sponsor_slug":"instylla-inc","status":"reported-late","is_pact":false,"days_late":285},{"registry_id":"NCT05254418","publication_url":"https://clinicaltrials.gov/study/NCT05254418","title":"Effects of Glucagon-Like Peptide-1 Agonists on Metabolism and Ectopic Fat Deposition in Chronic Kidney Disease: A Pilot and Feasibility Study","has_exemption":false,"start_date":"2022-03-15","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05238675","publication_url":"https://clinicaltrials.gov/study/NCT05238675","title":"A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-finding Study Evaluating Efficacy, Safety and Tolerability of BI 1291583 qd Over at Least 24 Weeks in Patients With Bronchiectasis (AirleafTM)","has_exemption":true,"start_date":"2022-04-28","completion_date":"2024-05-01","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301335","publication_url":"https://clinicaltrials.gov/study/NCT05301335","title":"Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder","has_exemption":false,"start_date":"2022-05-25","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"SpineX Inc.","sponsor_slug":"spinex-inc","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT04904562","publication_url":"https://clinicaltrials.gov/study/NCT04904562","title":"Angiotensin II as a First-line Vasopressor for Distributive Shock During or After Heart Transplantation or Durable Left Ventricular Assist Device Implantation: A Pilot Study","has_exemption":false,"start_date":"2022-06-01","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported-late","is_pact":false,"days_late":327},{"registry_id":"NCT05309460","publication_url":"https://clinicaltrials.gov/study/NCT05309460","title":"Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial","has_exemption":false,"start_date":"2022-06-20","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Nebraska Methodist Health System","sponsor_slug":"nebraska-methodist-health-system","status":"reported-late","is_pact":false,"days_late":18},{"registry_id":"NCT05419388","publication_url":"https://clinicaltrials.gov/study/NCT05419388","title":"A Randomized, Open-Label, Multicenter, Phase II Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma","has_exemption":true,"start_date":"2022-08-15","completion_date":"2024-05-01","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05383677","publication_url":"https://clinicaltrials.gov/study/NCT05383677","title":"ANIfrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome - Efficacy and Safety Assessment in a Randomized, Double-blind, Placebo-controlled Phase-IIa Proof-of-concept Trial (ANISE-II)","has_exemption":false,"start_date":"2022-10-01","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"University Medical Center Groningen","sponsor_slug":"university-medical-center-groningen","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT05560867","publication_url":"https://clinicaltrials.gov/study/NCT05560867","title":"Neural Mechanisms of Motor Recovery With Technology Assisted Training for Post-stroke Hemiparesis","has_exemption":false,"start_date":"2022-12-14","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"reported-late","is_pact":false,"days_late":349},{"registry_id":"NCT05607979","publication_url":"https://clinicaltrials.gov/study/NCT05607979","title":"The RENEW Study: (Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds): A Non-Inferiority Study","has_exemption":false,"start_date":"2022-12-15","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Lavior Pharma Inc.","sponsor_slug":"lavior-pharma-inc","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT05458024","publication_url":"https://clinicaltrials.gov/study/NCT05458024","title":"Randomized Controlled Trial of Vitamin D to Reduce Racial Disparity in Chronic Pain Following Motor Vehicle Collision","has_exemption":false,"start_date":"2023-01-24","completion_date":"2024-05-01","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05844852","publication_url":"https://clinicaltrials.gov/study/NCT05844852","title":"Optos P200TE US Reference Database Study","has_exemption":false,"start_date":"2023-03-14","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Optos, PLC.","sponsor_slug":"optos-plc","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT06509451","publication_url":"https://clinicaltrials.gov/study/NCT06509451","title":"Retention Rate of Giomer S-PRG Filler Containing Pit and Fissure Sealant Applied With or Without Etching by Using Split Mouth Technique: Randomized Clinical Trial","has_exemption":false,"start_date":"2023-05-01","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT05721729","publication_url":"https://clinicaltrials.gov/study/NCT05721729","title":"Phase 2 Crossover, Randomized, Placebo-Controlled, Single-Blind, Repeat Dose Study in Post-Bariatric Hypoglycemia Subjects to Determine the Effect of Mizagliflozin on Adverse Events and Postprandial Glucose Excursions","has_exemption":false,"start_date":"2023-06-23","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Vogenx, Inc.","sponsor_slug":"vogenx-inc","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT06093815","publication_url":"https://clinicaltrials.gov/study/NCT06093815","title":"Prospective, Single Site, Controlled Comparative Study to Identify and Assess Tissue Responses After Injection With Various Biostimulatory Products","has_exemption":false,"start_date":"2023-09-08","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Merz North America, Inc.","sponsor_slug":"merz-north-america-inc","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT05869877","publication_url":"https://clinicaltrials.gov/study/NCT05869877","title":"The PIV5Rights Safety and Quality Bundle","has_exemption":false,"start_date":"2024-03-25","completion_date":"2024-05-01","has_results":false,"results_due":true,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"overdue","is_pact":false,"days_late":356},{"registry_id":"NCT03641469","publication_url":"https://clinicaltrials.gov/study/NCT03641469","title":"Green Sun Medical Dynamic Scoliosis Brace","has_exemption":false,"start_date":"2018-05-24","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Green Sun medical","sponsor_slug":"green-sun-medical","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03739710","publication_url":"https://clinicaltrials.gov/study/NCT03739710","title":"A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in NSCLC Participants","has_exemption":false,"start_date":"2019-01-24","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03918915","publication_url":"https://clinicaltrials.gov/study/NCT03918915","title":"A Multicenter, Randomized, Double-masked, Vehicle-controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children","has_exemption":true,"start_date":"2019-04-24","completion_date":"2024-05-02","has_results":false,"results_due":false,"sponsor_name":"Sydnexis, Inc.","sponsor_slug":"sydnexis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04140162","publication_url":"https://clinicaltrials.gov/study/NCT04140162","title":"Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy","has_exemption":false,"start_date":"2020-10-05","completion_date":"2024-05-02","has_results":false,"results_due":true,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04664881","publication_url":"https://clinicaltrials.gov/study/NCT04664881","title":"Home Telemonitoring In Patients After Myocardial Infarction, HELP ME Trial","has_exemption":false,"start_date":"2020-10-14","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04767529","publication_url":"https://clinicaltrials.gov/study/NCT04767529","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)","has_exemption":false,"start_date":"2021-02-16","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Akero Therapeutics, Inc","sponsor_slug":"akero-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04659928","publication_url":"https://clinicaltrials.gov/study/NCT04659928","title":"Evaluation of Aerosol in a Dental Clinic","has_exemption":false,"start_date":"2021-07-21","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported-late","is_pact":false,"days_late":47},{"registry_id":"NCT06926673","publication_url":"https://clinicaltrials.gov/study/NCT06926673","title":"A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in NSCLC Participants","has_exemption":false,"start_date":"2021-12-23","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05173012","publication_url":"https://clinicaltrials.gov/study/NCT05173012","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of SAGE-324 for the Treatment of Essential Tremor","has_exemption":false,"start_date":"2022-01-05","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Sage Therapeutics","sponsor_slug":"sage-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05161481","publication_url":"https://clinicaltrials.gov/study/NCT05161481","title":"Randomised, Double-blind, Placebo-controlled and Parallel Group Trial to Investigate the Effects of Two Doses (Up-titration to a Fixed Dose Regimen) of Oral BI 685509 on Portal Hypertension After 24 Weeks Treatment in Patients With Clinically Significant Portal Hypertension (CSPH) in Compensated Cirrhosis","has_exemption":false,"start_date":"2022-04-27","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05432167","publication_url":"https://clinicaltrials.gov/study/NCT05432167","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease","has_exemption":false,"start_date":"2022-04-29","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05685732","publication_url":"https://clinicaltrials.gov/study/NCT05685732","title":"A Multicenter, Dose-Optimized, Randomized, Double Blind, Efficacy and Safety Study With Azstarys® in Children 4 to 12 Years of Age With Attention Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2023-03-22","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Corium, Inc.","sponsor_slug":"corium-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05796583","publication_url":"https://clinicaltrials.gov/study/NCT05796583","title":"Pulsed Electromagnetic Fields for Postoperative and Post-Amputation Analgesia: A Randomized, Participant- and Observer-Masked, Sham-Controlled Pilot Study","has_exemption":false,"start_date":"2023-04-04","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05753670","publication_url":"https://clinicaltrials.gov/study/NCT05753670","title":"Effect of Preoperative Single-dose Tamsulosin on Postoperative Urinary Retention After Mid-urethral Sling Placement: a Randomized, Double-blinded, Placebo-controlled Trial","has_exemption":false,"start_date":"2023-07-01","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"reported-late","is_pact":false,"days_late":61},{"registry_id":"NCT05959629","publication_url":"https://clinicaltrials.gov/study/NCT05959629","title":"A Clinical Use of Er,Cr:YSGG Laser: an Anti-biofilm Treatment","has_exemption":false,"start_date":"2023-10-11","completion_date":"2024-05-02","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported-late","is_pact":false,"days_late":11},{"registry_id":"NCT06128369","publication_url":"https://clinicaltrials.gov/study/NCT06128369","title":"A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery","has_exemption":false,"start_date":"2023-12-18","completion_date":"2024-05-02","has_results":false,"results_due":true,"sponsor_name":"Oculis","sponsor_slug":"oculis","status":"reported-late","is_pact":false,"days_late":7},{"registry_id":"NCT01919619","publication_url":"https://clinicaltrials.gov/study/NCT01919619","title":"A Pilot Study of Lenalidomide Alternating With Ipilimumab Post Allogeneic and Autologous Stem Cell Transplantation","has_exemption":false,"start_date":"2013-11-04","completion_date":"2024-05-03","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT05144256","publication_url":"https://clinicaltrials.gov/study/NCT05144256","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Subjects With Pyruvate Kinase Deficiency Who Are Regularly Transfused, Followed by a 5-Year Open-label Extension Period","has_exemption":true,"start_date":"2022-06-08","completion_date":"2024-05-03","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05082025","publication_url":"https://clinicaltrials.gov/study/NCT05082025","title":"Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations","has_exemption":false,"start_date":"2022-09-27","completion_date":"2024-05-03","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported-late","is_pact":false,"days_late":24},{"registry_id":"NCT05372419","publication_url":"https://clinicaltrials.gov/study/NCT05372419","title":"An Open-Label, 24-Week Study to Investigate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color","has_exemption":false,"start_date":"2023-01-12","completion_date":"2024-05-03","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05887947","publication_url":"https://clinicaltrials.gov/study/NCT05887947","title":"Impact of E-cigarette Nicotine Concentration on Compensation, Cigarette Smoking, and Biomarkers of Exposure and Harm in Diverse Smokers","has_exemption":false,"start_date":"2023-02-20","completion_date":"2024-05-03","has_results":true,"results_due":true,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"reported-late","is_pact":false,"days_late":60},{"registry_id":"NCT05860647","publication_url":"https://clinicaltrials.gov/study/NCT05860647","title":"A Single Arm Study of Resting State Functional Magnetic Resonance Imaging (Rs-fMRI)-Guided Theta Burst Stimulation (TBS) in Primary Progressive Aphasia (PPA)","has_exemption":false,"start_date":"2023-10-02","completion_date":"2024-05-03","has_results":true,"results_due":true,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"reported-late","is_pact":false,"days_late":12},{"registry_id":"NCT03919175","publication_url":"https://clinicaltrials.gov/study/NCT03919175","title":"A Phase 2 Study of Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma","has_exemption":false,"start_date":"2019-09-01","completion_date":"2024-05-05","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":false,"days_late":273},{"registry_id":"NCT03757585","publication_url":"https://clinicaltrials.gov/study/NCT03757585","title":"An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)","has_exemption":false,"start_date":"2019-05-20","completion_date":"2024-05-06","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04456127","publication_url":"https://clinicaltrials.gov/study/NCT04456127","title":"Ablative Fractional CO2 Laser Revision for Burn Related Donor Site Scars: A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2020-01-21","completion_date":"2024-05-06","has_results":false,"results_due":true,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"overdue","is_pact":false,"days_late":351},{"registry_id":"NCT04029688","publication_url":"https://clinicaltrials.gov/study/NCT04029688","title":"A Phase I/II, Multicenter, Open-Label, Multi-Arm Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in the Treatment of Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemias or Solid Tumors","has_exemption":false,"start_date":"2020-01-27","completion_date":"2024-05-06","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04798768","publication_url":"https://clinicaltrials.gov/study/NCT04798768","title":"Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing","has_exemption":false,"start_date":"2021-07-20","completion_date":"2024-05-06","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05556356","publication_url":"https://clinicaltrials.gov/study/NCT05556356","title":"Effect of Perioperative Acetaminophen Dosing on Patients Undergoing Surgical Treatment of Basilar Thumb Arthritis","has_exemption":false,"start_date":"2022-09-13","completion_date":"2024-05-06","has_results":false,"results_due":true,"sponsor_name":"Indiana Hand to Shoulder Center","sponsor_slug":"indiana-hand-to-shoulder-center","status":"overdue","is_pact":false,"days_late":351},{"registry_id":"NCT05955040","publication_url":"https://clinicaltrials.gov/study/NCT05955040","title":"Treatment of Elevated Blood Pressures in Early Pregnancy","has_exemption":false,"start_date":"2023-07-11","completion_date":"2024-05-06","has_results":false,"results_due":true,"sponsor_name":"Marshall University","sponsor_slug":"marshall-university","status":"overdue","is_pact":false,"days_late":351},{"registry_id":"NCT00410956","publication_url":"https://clinicaltrials.gov/study/NCT00410956","title":"A Phase II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Bevacizumab (A Monoclonal Antibody to Vascular Endothelial Growth Factor-A), in Patients With Unresectable Primary Hepatic Malignancy","has_exemption":false,"start_date":"2007-05-09","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03652064","publication_url":"https://clinicaltrials.gov/study/NCT03652064","title":"A Phase 3 Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy","has_exemption":true,"start_date":"2018-11-06","completion_date":"2024-05-07","has_results":true,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03969901","publication_url":"https://clinicaltrials.gov/study/NCT03969901","title":"A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial Infection","has_exemption":false,"start_date":"2019-10-08","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04129411","publication_url":"https://clinicaltrials.gov/study/NCT04129411","title":"Pilot Study for the Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation","has_exemption":false,"start_date":"2020-06-15","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03549507","publication_url":"https://clinicaltrials.gov/study/NCT03549507","title":"Evaluation of Bowel Perfusion With Contrast-Enhanced Ultrasound in Necrotizing Enterocolitis","has_exemption":false,"start_date":"2020-11-04","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03549520","publication_url":"https://clinicaltrials.gov/study/NCT03549520","title":"Improved Diagnosis and Prognostication of Hypoxic Ischemic Injury in Neonates and Infants Using Contrast-Enhanced Ultrasound","has_exemption":false,"start_date":"2020-12-01","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04909450","publication_url":"https://clinicaltrials.gov/study/NCT04909450","title":"A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis Subjects","has_exemption":false,"start_date":"2021-08-24","completion_date":"2024-05-07","has_results":false,"results_due":true,"sponsor_name":"Claris Biotherapeutics, Inc.","sponsor_slug":"claris-biotherapeutics-inc","status":"reported-late","is_pact":false,"days_late":114},{"registry_id":"NCT04263363","publication_url":"https://clinicaltrials.gov/study/NCT04263363","title":"A Prospective Digital Quality Improvement Project to Apply Best Clinical Practices to Patients at High Risk of Respiratory Complications","has_exemption":false,"start_date":"2022-02-18","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05635045","publication_url":"https://clinicaltrials.gov/study/NCT05635045","title":"A Follow-Up Study to Monitor Therapeutic Response in Transthyretin Cardiac Amyloidosis Using Amyloid Reactive Peptide 124I-evuzamitide (AT01) PET/CT","has_exemption":false,"start_date":"2022-07-08","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported-late","is_pact":false,"days_late":40},{"registry_id":"NCT05465382","publication_url":"https://clinicaltrials.gov/study/NCT05465382","title":"The Effect of Early Saline Lavage on Synovial Fluid Composition Following Human Intra-Articular Ankle Fracture","has_exemption":true,"start_date":"2022-07-22","completion_date":"2024-05-07","has_results":true,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05463744","publication_url":"https://clinicaltrials.gov/study/NCT05463744","title":"A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy","has_exemption":false,"start_date":"2022-08-12","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05395091","publication_url":"https://clinicaltrials.gov/study/NCT05395091","title":"A Randomized, Double-Blind, Parallel Design, Repeat Dose, 2-arm, Multicenter Study Comparing the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profiles of AVT03 and US-Prolia® in Postmenopausal Women With Osteoporosis, ALVOBOND","has_exemption":false,"start_date":"2022-08-23","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Alvotech Swiss AG","sponsor_slug":"alvotech-swiss-ag","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05689333","publication_url":"https://clinicaltrials.gov/study/NCT05689333","title":"A Prospective, Single-arm, Non-comparative, Open-label, Monocular, Post Approval Study to Assess Safety and Device Performance of the Vista Vitrectomy Probe During Vitrectomy Surgery","has_exemption":false,"start_date":"2022-12-09","completion_date":"2024-05-07","has_results":false,"results_due":true,"sponsor_name":"VISTA Ophthalmics","sponsor_slug":"vista-ophthalmics","status":"overdue","is_pact":false,"days_late":350},{"registry_id":"NCT05853900","publication_url":"https://clinicaltrials.gov/study/NCT05853900","title":"A Randomized Double-blind, Parallel-Group, Virtual Study to Evaluate the Effectiveness and Safety of Two Digital Therapeutics in Late Adolescents and Adults for the Prevention of Episodic Migraine","has_exemption":false,"start_date":"2023-03-28","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Click Therapeutics, Inc.","sponsor_slug":"click-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":5},{"registry_id":"NCT05376319","publication_url":"https://clinicaltrials.gov/study/NCT05376319","title":"A Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Effect of Obinutuzumab Versus Rituximab in PR3-Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","has_exemption":false,"start_date":"2023-06-30","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05923814","publication_url":"https://clinicaltrials.gov/study/NCT05923814","title":"The Administration of Humanized Anti-CD25 Antibody for Prophylaxis of aGVHD in Patients Older Than 50y Underwent HID-HSCT","has_exemption":false,"start_date":"2023-07-07","completion_date":"2024-05-07","has_results":false,"results_due":true,"sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","sponsor_slug":"institute-of-hematology-blood-diseases-hospital-china","status":"overdue","is_pact":false,"days_late":350},{"registry_id":"NCT05938413","publication_url":"https://clinicaltrials.gov/study/NCT05938413","title":"Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)","has_exemption":false,"start_date":"2023-07-20","completion_date":"2024-05-07","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05650736","publication_url":"https://clinicaltrials.gov/study/NCT05650736","title":"JAK1 Inhibition in Granuloma Annulare: an Opportunity for Pathogenesis Directed Therapy","has_exemption":false,"start_date":"2023-10-27","completion_date":"2024-05-07","has_results":false,"results_due":true,"sponsor_name":"William Damsky","sponsor_slug":"william-damsky","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01725165","publication_url":"https://clinicaltrials.gov/study/NCT01725165","title":"A Randomized Phase II Study Assessing the Efficacy of Local Consolidative Therapy for Non-Small Cell Lung Cancer Patients With Induced Oligometastatic Disease","has_exemption":false,"start_date":"2012-11-28","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03400137","publication_url":"https://clinicaltrials.gov/study/NCT03400137","title":"Effects of Elevated Intraocular Pressure on the Lamina Cribrosa","has_exemption":false,"start_date":"2018-03-07","completion_date":"2024-05-08","has_results":false,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04897880","publication_url":"https://clinicaltrials.gov/study/NCT04897880","title":"A Phase II Study of Panobinostat in Pediatric, Adolescent and Young Adult Patients With Solid Tumors Including Osteosarcoma, Malignant Rhabdoid Tumor/Atypical Teratoid Rhabdoid Tumors and Neuroblastoma","has_exemption":false,"start_date":"2019-01-09","completion_date":"2024-05-08","has_results":false,"results_due":true,"sponsor_name":"Australian & New Zealand Children's Haematology/Oncology Group","sponsor_slug":"australian-new-zealand-childrens-haematologyoncology-group","status":"overdue","is_pact":false,"days_late":349},{"registry_id":"NCT04153149","publication_url":"https://clinicaltrials.gov/study/NCT04153149","title":"HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","has_exemption":false,"start_date":"2019-11-26","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":41},{"registry_id":"NCT04388475","publication_url":"https://clinicaltrials.gov/study/NCT04388475","title":"A Phase II Open-label Study Investigating the Efficacy, Safety and Pharmacokinetic Properties of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2020-06-12","completion_date":"2024-05-08","has_results":false,"results_due":true,"sponsor_name":"Oblato, Inc.","sponsor_slug":"oblato-inc","status":"overdue","is_pact":false,"days_late":349},{"registry_id":"NCT04474470","publication_url":"https://clinicaltrials.gov/study/NCT04474470","title":"A Phase 1/2 Study with Open-Label, Dose Escalation Phase Followed by Single-Arm Expansion At the Maximum Tolerated Dose to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of NT219 Injection Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer","has_exemption":false,"start_date":"2020-09-03","completion_date":"2024-05-08","has_results":false,"results_due":true,"sponsor_name":"TyrNovo Ltd.","sponsor_slug":"tyrnovo-ltd","status":"overdue","is_pact":false,"days_late":349},{"registry_id":"NCT04641962","publication_url":"https://clinicaltrials.gov/study/NCT04641962","title":"A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Assess the Efficacy, Safety and Tolerability of ASP0367 in Participants With Primary Mitochondrial Myopathy","has_exemption":false,"start_date":"2021-05-24","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Inc","sponsor_slug":"astellas-pharma-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05221320","publication_url":"https://clinicaltrials.gov/study/NCT05221320","title":"A Phase 2 Basket Trial of Ulixertinib (BVD-523) in Combination With Hydroxychloroquine in Patients With Advanced GI Malignancies Harboring Mitogen-activated Protein Kinase (MAPK) Pathway Mutations (BVD-523-HCQ)","has_exemption":false,"start_date":"2022-05-26","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"BioMed Valley Discoveries, Inc","sponsor_slug":"biomed-valley-discoveries-inc","status":"reported-late","is_pact":false,"days_late":71},{"registry_id":"NCT05579769","publication_url":"https://clinicaltrials.gov/study/NCT05579769","title":"A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies","has_exemption":false,"start_date":"2023-03-14","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06023394","publication_url":"https://clinicaltrials.gov/study/NCT06023394","title":"Laryngeal Mask Airway Versus Endotracheal Intubation for Laparoscopic Inguinal Hernia Repair","has_exemption":false,"start_date":"2023-03-27","completion_date":"2024-05-08","has_results":true,"results_due":true,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02773030","publication_url":"https://clinicaltrials.gov/study/NCT02773030","title":"Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 As Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma","has_exemption":false,"start_date":"2016-10-14","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04267120","publication_url":"https://clinicaltrials.gov/study/NCT04267120","title":"A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)","has_exemption":false,"start_date":"2020-07-29","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04569032","publication_url":"https://clinicaltrials.gov/study/NCT04569032","title":"A Dual-cohort, Open-label, Phase 2 Study of Brentuximab Vedotin and CHP (A+CHP) in the Frontline Treatment of Subjects With Peripheral T-cell Lymphoma (PTCL) With Less Than 10% CD30 Expression","has_exemption":false,"start_date":"2020-11-12","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04915846","publication_url":"https://clinicaltrials.gov/study/NCT04915846","title":"TAM4MTM: a Phase 1/2 Randomized, Placebo-Controlled, Double-Blinded, Single Crossover Study to Determine the Safety and Efficacy of Tamoxifen Therapy for Myotubular Myopathy (XLMTM)","has_exemption":false,"start_date":"2020-12-18","completion_date":"2024-05-09","has_results":false,"results_due":true,"sponsor_name":"James Dowling","sponsor_slug":"james-dowling","status":"overdue","is_pact":false,"days_late":348},{"registry_id":"NCT05082012","publication_url":"https://clinicaltrials.gov/study/NCT05082012","title":"Prospective Clinical StuDy of Tri-planar Tarsometatarsal (TMT) ArthroDesis With Early Weight-Bearing After Lapiplasty® ProceDure Through a Mini-Incision™ Approach (Mini3D)","has_exemption":false,"start_date":"2021-09-17","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Treace Medical Concepts, Inc.","sponsor_slug":"treace-medical-concepts-inc","status":"reported-late","is_pact":false,"days_late":108},{"registry_id":"NCT05506930","publication_url":"https://clinicaltrials.gov/study/NCT05506930","title":"Intrathecal Morphine Versus Bilateral Quadratus Lumborum Blocks for Perioperative Analgesia in Pediatric Patients Undergoing Open Lower Abdominal Procedures: A Prospective Randomized Trial","has_exemption":false,"start_date":"2022-08-17","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05700227","publication_url":"https://clinicaltrials.gov/study/NCT05700227","title":"Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer: A Prospective Trial of an Individualized Approach for Reducing Bowel and Bladder Toxicity (ARTIA-Bladder)","has_exemption":false,"start_date":"2023-02-02","completion_date":"2024-05-09","has_results":false,"results_due":true,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"overdue","is_pact":false,"days_late":348},{"registry_id":"NCT05517902","publication_url":"https://clinicaltrials.gov/study/NCT05517902","title":"A Phase 3 Multicenter, Single-Arm, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of StrataGraft® Construct in Pediatric Subjects With Deep Partial Thickness (DPT) Thermal Burns","has_exemption":false,"start_date":"2023-04-28","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Stratatech, a Mallinckrodt Company","sponsor_slug":"stratatech-a-mallinckrodt-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06032286","publication_url":"https://clinicaltrials.gov/study/NCT06032286","title":"Evaluation of Efficacy and Safety of the Skinstylus Sterilock Microneedling System for the Treatment of Facial Wrinkles","has_exemption":false,"start_date":"2023-09-08","completion_date":"2024-05-09","has_results":false,"results_due":true,"sponsor_name":"Beauty Health","sponsor_slug":"beauty-health","status":"overdue","is_pact":false,"days_late":348},{"registry_id":"NCT06107725","publication_url":"https://clinicaltrials.gov/study/NCT06107725","title":"Effect of Oral Minocycline on Acute Stroke Outcome: A Randomized Open Label Prospective Study","has_exemption":false,"start_date":"2023-11-01","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Maimonides Medical Center","sponsor_slug":"maimonides-medical-center","status":"reported-late","is_pact":false,"days_late":167},{"registry_id":"NCT06240091","publication_url":"https://clinicaltrials.gov/study/NCT06240091","title":"An Exploratory Open-Label Potency and Precision Investigation of a Relational Agent Intervention","has_exemption":false,"start_date":"2024-03-13","completion_date":"2024-05-09","has_results":true,"results_due":true,"sponsor_name":"Woebot Health","sponsor_slug":"woebot-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02681302","publication_url":"https://clinicaltrials.gov/study/NCT02681302","title":"Phase Ib-IIA Study of Combined Check Point Inhibition After Autologous Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence","has_exemption":false,"start_date":"2016-06-07","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"reported-late","is_pact":true,"days_late":3},{"registry_id":"NCT03969212","publication_url":"https://clinicaltrials.gov/study/NCT03969212","title":"A Phase IIIB, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Efficacy Study of Baloxavir Marboxil for the Reduction of Direct Transmission of Influenza From Otherwise Healthy Patients to Household Contacts","has_exemption":false,"start_date":"2019-10-10","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04322097","publication_url":"https://clinicaltrials.gov/study/NCT04322097","title":"Characterizing Mechanisms of Upper Airway Obstruction During Drug-Induced Sleep Endoscopy (DISE)","has_exemption":true,"start_date":"2020-06-03","completion_date":"2024-05-10","has_results":true,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04656652","publication_url":"https://clinicaltrials.gov/study/NCT04656652","title":"Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-LUNG01)","has_exemption":false,"start_date":"2020-12-21","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05253209","publication_url":"https://clinicaltrials.gov/study/NCT05253209","title":"A Phase III Double-Blind, Randomized, Placebo Controlled, Multi Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects","has_exemption":false,"start_date":"2022-06-29","completion_date":"2024-05-10","has_results":false,"results_due":true,"sponsor_name":"Asklepion Pharmaceuticals, LLC","sponsor_slug":"asklepion-pharmaceuticals-llc","status":"overdue","is_pact":false,"days_late":347},{"registry_id":"NCT05385952","publication_url":"https://clinicaltrials.gov/study/NCT05385952","title":"A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery","has_exemption":true,"start_date":"2022-08-04","completion_date":"2024-05-10","has_results":true,"results_due":false,"sponsor_name":"GATT Technologies BV","sponsor_slug":"gatt-technologies-bv","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05405556","publication_url":"https://clinicaltrials.gov/study/NCT05405556","title":"Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients","has_exemption":false,"start_date":"2022-10-17","completion_date":"2024-05-10","has_results":false,"results_due":true,"sponsor_name":"Martina McGrath, MD","sponsor_slug":"martina-mcgrath-md","status":"reported-late","is_pact":false,"days_late":312},{"registry_id":"NCT04609020","publication_url":"https://clinicaltrials.gov/study/NCT04609020","title":"Prospective, Multi-site Study to Evaluate Subject Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment","has_exemption":false,"start_date":"2023-02-15","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07213687","publication_url":"https://clinicaltrials.gov/study/NCT07213687","title":"Effectiveness of Low-Dose Ketamine and Intravenous Lidocaine Versus Fentanyl for Postoperative Pain for Patients Undergoing Elective Gynecologic Surgery Under General Anesthesia: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-06-10","completion_date":"2024-05-10","has_results":false,"results_due":true,"sponsor_name":"Dilla University","sponsor_slug":"dilla-university","status":"overdue","is_pact":false,"days_late":347},{"registry_id":"NCT05908344","publication_url":"https://clinicaltrials.gov/study/NCT05908344","title":"Use of the Frequen-ZZZ Sleep Pad to Increase Restorative Sleep: A Proof-of-Concept Study","has_exemption":false,"start_date":"2023-07-21","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"Kunasan Inc.","sponsor_slug":"kunasan-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05506449","publication_url":"https://clinicaltrials.gov/study/NCT05506449","title":"Early Impella® Support in Patients With ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The RECOVER IV Trial","has_exemption":false,"start_date":"2023-10-28","completion_date":"2024-05-10","has_results":false,"results_due":true,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"overdue","is_pact":false,"days_late":347},{"registry_id":"NCT06450457","publication_url":"https://clinicaltrials.gov/study/NCT06450457","title":"Effects of High Intensity Stepping Training on Gait in Patients With Ataxia","has_exemption":false,"start_date":"2024-03-26","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06354998","publication_url":"https://clinicaltrials.gov/study/NCT06354998","title":"Randomized, Observer-Blind, Active-Controlled, Clinical Trial to Assess the Immunogenicity of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults","has_exemption":false,"start_date":"2024-04-08","completion_date":"2024-05-10","has_results":true,"results_due":true,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01996865","publication_url":"https://clinicaltrials.gov/study/NCT01996865","title":"A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab Maintenance in Subjects With Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma","has_exemption":false,"start_date":"2014-04-01","completion_date":"2024-05-11","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT05559320","publication_url":"https://clinicaltrials.gov/study/NCT05559320","title":"Effects of a Novel, Home-based Training Program Using a Joystick-operated, Modified, Powered Ride-on-car on Bilateral Upper Extremity Function in Children With Hemiplegic Cerebral Palsy","has_exemption":false,"start_date":"2022-11-15","completion_date":"2024-05-11","has_results":true,"results_due":true,"sponsor_name":"University of Connecticut","sponsor_slug":"university-of-connecticut","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05848128","publication_url":"https://clinicaltrials.gov/study/NCT05848128","title":"A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Clinical Study to Assess the Efficacy and Safety of 5% Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","has_exemption":false,"start_date":"2023-06-28","completion_date":"2024-05-11","has_results":false,"results_due":true,"sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","sponsor_slug":"mimetogen-pharmaceuticals-usa-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06052046","publication_url":"https://clinicaltrials.gov/study/NCT06052046","title":"How Does Total30 for Astigmatism Perform During a Long Day of Wear?","has_exemption":false,"start_date":"2023-10-15","completion_date":"2024-05-11","has_results":false,"results_due":true,"sponsor_name":"Southern College of Optometry","sponsor_slug":"southern-college-of-optometry","status":"overdue","is_pact":false,"days_late":346},{"registry_id":"NCT06400914","publication_url":"https://clinicaltrials.gov/study/NCT06400914","title":"Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere","has_exemption":false,"start_date":"2024-04-03","completion_date":"2024-05-11","has_results":true,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"reported-late","is_pact":false,"days_late":16},{"registry_id":"NCT02715609","publication_url":"https://clinicaltrials.gov/study/NCT02715609","title":"A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2016-06-15","completion_date":"2024-05-12","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04933474","publication_url":"https://clinicaltrials.gov/study/NCT04933474","title":"Transcending COVID-19 Barriers to Pain Care in Rural America: Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain","has_exemption":false,"start_date":"2022-03-23","completion_date":"2024-05-12","has_results":true,"results_due":true,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06165627","publication_url":"https://clinicaltrials.gov/study/NCT06165627","title":"Comparison of Clinical Performance of Two Monthly Replacement Toric Soft Contact Lenses","has_exemption":false,"start_date":"2024-01-23","completion_date":"2024-05-12","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00984399","publication_url":"https://clinicaltrials.gov/study/NCT00984399","title":"Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen","has_exemption":false,"start_date":"2009-09-22","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03965923","publication_url":"https://clinicaltrials.gov/study/NCT03965923","title":"Phase 3b, Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy","has_exemption":false,"start_date":"2020-01-09","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04726410","publication_url":"https://clinicaltrials.gov/study/NCT04726410","title":"Cold Stored Platelet Early Intervention in Traumatic Brain Injury Trial","has_exemption":false,"start_date":"2022-03-21","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"Jason Sperry","sponsor_slug":"jason-sperry","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04176965","publication_url":"https://clinicaltrials.gov/study/NCT04176965","title":"Clinical Investigation of the Safety and Effectiveness of FINEVISION HP Trifocal IOL","has_exemption":false,"start_date":"2022-04-28","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"Beaver-Visitec International, Inc.","sponsor_slug":"beaver-visitec-international-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05011851","publication_url":"https://clinicaltrials.gov/study/NCT05011851","title":"An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome","has_exemption":true,"start_date":"2022-07-12","completion_date":"2024-05-13","has_results":false,"results_due":false,"sponsor_name":"Neuren Pharmaceuticals Limited","sponsor_slug":"neuren-pharmaceuticals-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407311","publication_url":"https://clinicaltrials.gov/study/NCT05407311","title":"64Cu-SAR-BBN Positron Emission Tomography: A Phase 2 Study of Participants With PSMA-negative Biochemical Recurrence of Prostate Cancer","has_exemption":true,"start_date":"2022-09-19","completion_date":"2024-05-13","has_results":true,"results_due":false,"sponsor_name":"Clarity Pharmaceuticals Ltd","sponsor_slug":"clarity-pharmaceuticals-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05530577","publication_url":"https://clinicaltrials.gov/study/NCT05530577","title":"Effects of Semaglutide on Nicotine Intake and Smoking Lapse","has_exemption":true,"start_date":"2022-10-07","completion_date":"2024-05-13","has_results":true,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06083493","publication_url":"https://clinicaltrials.gov/study/NCT06083493","title":"Neuromodulation of Conscious Perception: Investigating Thalamic Roles Through Ultrasonic Stimulation","has_exemption":false,"start_date":"2023-11-07","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06024174","publication_url":"https://clinicaltrials.gov/study/NCT06024174","title":"Phase 1/2 Open-label Study of BMS-986466 in Combination With Adagrasib With or Without Cetuximab in Participants With KRAS G12C-mutant Advanced Solid Tumors","has_exemption":false,"start_date":"2023-11-09","completion_date":"2024-05-13","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04625660","publication_url":"https://clinicaltrials.gov/study/NCT04625660","title":"The DETOUR2 Continued Access Clinical Trial - The Detour Endovascular Technique for Long OcclUsive Fem-pop Revascularization - Continued Access Clinical Trial","has_exemption":false,"start_date":"2021-04-07","completion_date":"2024-05-14","has_results":false,"results_due":true,"sponsor_name":"Endologix","sponsor_slug":"endologix","status":"overdue","is_pact":false,"days_late":343},{"registry_id":"NCT04586504","publication_url":"https://clinicaltrials.gov/study/NCT04586504","title":"Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children","has_exemption":false,"start_date":"2021-09-08","completion_date":"2024-05-14","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported-late","is_pact":false,"days_late":14},{"registry_id":"NCT05071664","publication_url":"https://clinicaltrials.gov/study/NCT05071664","title":"A Phase 2a, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis","has_exemption":true,"start_date":"2021-10-25","completion_date":"2024-05-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05087628","publication_url":"https://clinicaltrials.gov/study/NCT05087628","title":"Phase 2a, Randomized, Double-blind, Placebo-controlled Trial of PRV-3279 EVAluation In Lupus","has_exemption":true,"start_date":"2022-01-20","completion_date":"2024-05-14","has_results":true,"results_due":false,"sponsor_name":"Provention Bio, a Sanofi Company","sponsor_slug":"provention-bio-a-sanofi-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05408637","publication_url":"https://clinicaltrials.gov/study/NCT05408637","title":"Transcranial Photobiomodulation for Executive Function in Bipolar Disorder (TPEB)","has_exemption":false,"start_date":"2022-08-09","completion_date":"2024-05-14","has_results":true,"results_due":true,"sponsor_name":"Paolo Cassano","sponsor_slug":"paolo-cassano","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT05844397","publication_url":"https://clinicaltrials.gov/study/NCT05844397","title":"Comparison of Clinical Outcomes of SMILE vs. LASIK Using Contoura With Phorcides","has_exemption":false,"start_date":"2023-05-09","completion_date":"2024-05-14","has_results":false,"results_due":true,"sponsor_name":"59th Medical Wing","sponsor_slug":"59th-medical-wing","status":"reported-late","is_pact":false,"days_late":89},{"registry_id":"NCT05720312","publication_url":"https://clinicaltrials.gov/study/NCT05720312","title":"A Preliminary Investigation of Two Repetitive Transcranial Magnetic Stimulation (rTMS) Strategies to Treat Cannabis Use Disorder","has_exemption":false,"start_date":"2023-07-01","completion_date":"2024-05-14","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06756854","publication_url":"https://clinicaltrials.gov/study/NCT06756854","title":"Evaluation of Low-Level Laser Therapy as Adjunctive to the Injectable Platelet-Rich Fibrin in the Management of Patients With Thin Gingival Phenotype.","has_exemption":false,"start_date":"2023-09-12","completion_date":"2024-05-14","has_results":false,"results_due":true,"sponsor_name":"Faculty of Dental Medicine for Girls","sponsor_slug":"faculty-of-dental-medicine-for-girls","status":"overdue","is_pact":false,"days_late":343},{"registry_id":"NCT03377517","publication_url":"https://clinicaltrials.gov/study/NCT03377517","title":"A Pilot Study of Stereotactic Radiosurgical Hypophysectomy for Intractable Pain From Bone Metastases","has_exemption":false,"start_date":"2018-05-08","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT04031989","publication_url":"https://clinicaltrials.gov/study/NCT04031989","title":"Phase Signal Acquisition System (PSAQ): Repository of Phase Signals for Pulmonary Hypertension Algorithm Development","has_exemption":false,"start_date":"2019-04-15","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Analytics For Life","sponsor_slug":"analytics-for-life","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT04040959","publication_url":"https://clinicaltrials.gov/study/NCT04040959","title":"Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD","has_exemption":false,"start_date":"2019-11-19","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT04570839","publication_url":"https://clinicaltrials.gov/study/NCT04570839","title":"A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination With BMS-986207 (Anti-TIGIT Antibody) and Nivolumab in Subjects With Advanced Solid Tumors.","has_exemption":false,"start_date":"2020-08-31","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Compugen Ltd","sponsor_slug":"compugen-ltd","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT04435626","publication_url":"https://clinicaltrials.gov/study/NCT04435626","title":"A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Finerenone on Morbidity and Mortality in Participants With Heart Failure (NYHA II-IV) and Left Ventricular Ejection Fraction ≥ 40% (LVEF ≥ 40%)","has_exemption":false,"start_date":"2020-09-14","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04281485","publication_url":"https://clinicaltrials.gov/study/NCT04281485","title":"A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF 06939926 FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY","has_exemption":false,"start_date":"2020-11-05","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04538755","publication_url":"https://clinicaltrials.gov/study/NCT04538755","title":"Effect of DAW2020 on Endotypic Traits in OSA","has_exemption":false,"start_date":"2020-11-15","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT04784455","publication_url":"https://clinicaltrials.gov/study/NCT04784455","title":"Multicentre Study of Nomacopan (rVA576) in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy","has_exemption":false,"start_date":"2021-02-01","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"AKARI Therapeutics","sponsor_slug":"akari-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04681066","publication_url":"https://clinicaltrials.gov/study/NCT04681066","title":"A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of Auxora in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome","has_exemption":false,"start_date":"2021-03-24","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"CalciMedica, Inc.","sponsor_slug":"calcimedica-inc","status":"reported-late","is_pact":false,"days_late":110},{"registry_id":"NCT04299464","publication_url":"https://clinicaltrials.gov/study/NCT04299464","title":"A Phase II Multicenter, Randomized, Double-Blind, 12-Week Treatment, 3-Arm, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)","has_exemption":false,"start_date":"2021-03-31","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05022303","publication_url":"https://clinicaltrials.gov/study/NCT05022303","title":"A Phase 2a (Proof of Concept), Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AT1001 for the Treatment of COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)","has_exemption":false,"start_date":"2021-10-01","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT05057429","publication_url":"https://clinicaltrials.gov/study/NCT05057429","title":"A Bioelectric Dressing for Post De-Roofing Treatment of Hidradenitis Suppurativa (HS)","has_exemption":false,"start_date":"2021-10-11","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported-late","is_pact":false,"days_late":21},{"registry_id":"NCT05116241","publication_url":"https://clinicaltrials.gov/study/NCT05116241","title":"Phase 2b Placebo-Controlled Randomized Study of BPZE1 Intranasal Pertussis Vaccine in Healthy School-Age Children to Assess Immunological Response and Safety of a Single Dose BPZE1 With/Without Coadministration of Tdap (Boostrix™)","has_exemption":false,"start_date":"2021-11-11","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"ILiAD Biotechnologies","sponsor_slug":"iliad-biotechnologies","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05275400","publication_url":"https://clinicaltrials.gov/study/NCT05275400","title":"A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)","has_exemption":false,"start_date":"2022-03-08","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05426460","publication_url":"https://clinicaltrials.gov/study/NCT05426460","title":"AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior","has_exemption":false,"start_date":"2022-04-29","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Cynthia Conklin","sponsor_slug":"cynthia-conklin","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05826678","publication_url":"https://clinicaltrials.gov/study/NCT05826678","title":"A Pilot Clinical Trial to Assess Feasibility, Facilitators and Barriers of Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes","has_exemption":false,"start_date":"2022-09-22","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Joslin Diabetes Center","sponsor_slug":"joslin-diabetes-center","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT05358353","publication_url":"https://clinicaltrials.gov/study/NCT05358353","title":"A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)","has_exemption":false,"start_date":"2022-10-18","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"ReFlow Medical, Inc.","sponsor_slug":"reflow-medical-inc","status":"reported-late","is_pact":false,"days_late":90},{"registry_id":"NCT05880277","publication_url":"https://clinicaltrials.gov/study/NCT05880277","title":"Diagnostic Point of Care Ultrasound of Patellar Tendon in Female Collegiate Athletes","has_exemption":false,"start_date":"2023-02-17","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Youngstown State University","sponsor_slug":"youngstown-state-university","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT06047366","publication_url":"https://clinicaltrials.gov/study/NCT06047366","title":"Buffered vs Unbuffered Local Anesthesia Using Lidocaine, Carbocaine, and Articaine in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis","has_exemption":false,"start_date":"2023-12-05","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06186388","publication_url":"https://clinicaltrials.gov/study/NCT06186388","title":"TEMPO (iMOvifa) Glaucoma Screening","has_exemption":false,"start_date":"2023-12-05","completion_date":"2024-05-15","has_results":false,"results_due":true,"sponsor_name":"Cape Fear Eye Institute","sponsor_slug":"cape-fear-eye-institute","status":"overdue","is_pact":false,"days_late":342},{"registry_id":"NCT06164743","publication_url":"https://clinicaltrials.gov/study/NCT06164743","title":"A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery","has_exemption":false,"start_date":"2024-01-11","completion_date":"2024-05-15","has_results":true,"results_due":true,"sponsor_name":"VivaVision Biotech, Inc","sponsor_slug":"vivavision-biotech-inc","status":"reported-late","is_pact":false,"days_late":4},{"registry_id":"NCT01919086","publication_url":"https://clinicaltrials.gov/study/NCT01919086","title":"Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma","has_exemption":false,"start_date":"2013-08-06","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03811821","publication_url":"https://clinicaltrials.gov/study/NCT03811821","title":"Comparative Effectiveness of Biofeedback and Injectable Bulking Agents for Treatment of Fecal Incontinence: The Fecal Incontinence Treatment (FIT) Study","has_exemption":false,"start_date":"2019-02-01","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04539964","publication_url":"https://clinicaltrials.gov/study/NCT04539964","title":"Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study","has_exemption":false,"start_date":"2021-01-11","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"SetPoint Medical Corporation","sponsor_slug":"setpoint-medical-corporation","status":"reported-late","is_pact":false,"days_late":115},{"registry_id":"NCT04717466","publication_url":"https://clinicaltrials.gov/study/NCT04717466","title":"Brain Morphological Changes Accompanied by Effective Biologic Treatments for Psoriasis and Their Associations With the Improvement of Well-being, Itch, and Pain","has_exemption":false,"start_date":"2021-06-29","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05614284","publication_url":"https://clinicaltrials.gov/study/NCT05614284","title":"A Prospective, Post-Market, Multicenter Comparative Analysis of the Efficacy of Virtuos and Autograft Bone Graft in Lumbar Fusion Surgery","has_exemption":false,"start_date":"2022-11-14","completion_date":"2024-05-16","has_results":false,"results_due":true,"sponsor_name":"Orthofix Inc.","sponsor_slug":"orthofix-inc","status":"overdue","is_pact":false,"days_late":341},{"registry_id":"NCT05616013","publication_url":"https://clinicaltrials.gov/study/NCT05616013","title":"A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of Intravenous Bimagrumab, Alone or in Addition to Open Label Subcutaneous Semaglutide, to Investigate the Efficacy and Safety in Overweight or Obese Men and Women","has_exemption":false,"start_date":"2022-11-16","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04998318","publication_url":"https://clinicaltrials.gov/study/NCT04998318","title":"Compare the Performance of the Pocket Colposcope to VIA/VILI for Triage of HPV+ Women in Kenya","has_exemption":false,"start_date":"2022-11-28","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04854096","publication_url":"https://clinicaltrials.gov/study/NCT04854096","title":"A Phase 2b, Open-label, Multicenter, Randomized, Controlled, 2-Arm Study to Assess the Efficacy and Safety of Orally Administered NS-018 Versus Best Available Therapy in Subjects With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/μL)","has_exemption":false,"start_date":"2023-01-31","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"NS Pharma, Inc.","sponsor_slug":"ns-pharma-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05738486","publication_url":"https://clinicaltrials.gov/study/NCT05738486","title":"Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults With Early Symptomatic Alzheimer's Disease","has_exemption":false,"start_date":"2023-02-28","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06532045","publication_url":"https://clinicaltrials.gov/study/NCT06532045","title":"Effect of Transcutaneous Electrical Nerve Stimulation on Patients With Palmar Hyperhidrosis","has_exemption":false,"start_date":"2023-07-01","completion_date":"2024-05-16","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":341},{"registry_id":"NCT06037408","publication_url":"https://clinicaltrials.gov/study/NCT06037408","title":"The Effect of Sodium Pyruvate Nasal Spray on Coughing in Patients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2023-08-15","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Cellular Sciences, inc.","sponsor_slug":"cellular-sciences-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06081309","publication_url":"https://clinicaltrials.gov/study/NCT06081309","title":"Electroencephalogram (EEG) Personalized Transcranial Magnetic Stimulation (eTMS) for Post-Traumatic Stress Disorder","has_exemption":false,"start_date":"2023-11-20","completion_date":"2024-05-16","has_results":true,"results_due":true,"sponsor_name":"Wave Neuroscience","sponsor_slug":"wave-neuroscience","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04704284","publication_url":"https://clinicaltrials.gov/study/NCT04704284","title":"Comparative Analysis of Zero Echo-time MRI and CT for Pediatric Craniosynostosis","has_exemption":false,"start_date":"2020-04-14","completion_date":"2024-05-17","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04614974","publication_url":"https://clinicaltrials.gov/study/NCT04614974","title":"Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia","has_exemption":false,"start_date":"2020-11-18","completion_date":"2024-05-17","has_results":true,"results_due":true,"sponsor_name":"Reema Padia","sponsor_slug":"reema-padia","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05328297","publication_url":"https://clinicaltrials.gov/study/NCT05328297","title":"A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression","has_exemption":false,"start_date":"2022-06-03","completion_date":"2024-05-17","has_results":true,"results_due":true,"sponsor_name":"Janssen Pharmaceutica N.V., Belgium","sponsor_slug":"janssen-pharmaceutica-nv-belgium","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05456529","publication_url":"https://clinicaltrials.gov/study/NCT05456529","title":"A Phase 3, Open-Label, One-Year Safety Study of Ruxolitinib Cream in Adolescents (Ages ≥ 12 Years to < 18 Years) With Atopic Dermatitis","has_exemption":false,"start_date":"2022-09-01","completion_date":"2024-05-17","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05615948","publication_url":"https://clinicaltrials.gov/study/NCT05615948","title":"An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression","has_exemption":false,"start_date":"2022-12-06","completion_date":"2024-05-17","has_results":false,"results_due":true,"sponsor_name":"Theresa Jacob, PhD, MPH","sponsor_slug":"theresa-jacob-phd-mph","status":"overdue","is_pact":false,"days_late":340},{"registry_id":"NCT05761574","publication_url":"https://clinicaltrials.gov/study/NCT05761574","title":"A Full-Factorial, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose Efficacy and Safety Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen, and Naproxen Sodium in Postoperative Dental Pain","has_exemption":true,"start_date":"2023-05-22","completion_date":"2024-05-17","has_results":false,"results_due":false,"sponsor_name":"Johnson & Johnson Consumer Inc. (J&JCI)","sponsor_slug":"johnson-johnson-consumer-inc-jjci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06502470","publication_url":"https://clinicaltrials.gov/study/NCT06502470","title":"Open Label Study to Explore Healing and Tissue Histopathology Following Ellacor Micro-Coring Procedures in an Abdominoplasty Model","has_exemption":false,"start_date":"2024-04-30","completion_date":"2024-05-17","has_results":false,"results_due":true,"sponsor_name":"Cytrellis Biosystems, Inc.","sponsor_slug":"cytrellis-biosystems-inc","status":"reported-late","is_pact":false,"days_late":300},{"registry_id":"NCT04097730","publication_url":"https://clinicaltrials.gov/study/NCT04097730","title":"Steroids and Cross-linking for Ulcer Treatment","has_exemption":false,"start_date":"2020-09-24","completion_date":"2024-05-18","has_results":false,"results_due":true,"sponsor_name":"Thomas M. Lietman","sponsor_slug":"thomas-m-lietman","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04202835","publication_url":"https://clinicaltrials.gov/study/NCT04202835","title":"A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) With ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD)","has_exemption":false,"start_date":"2020-10-14","completion_date":"2024-05-18","has_results":false,"results_due":true,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"overdue","is_pact":false,"days_late":339}]}